Mark Portnoy - Dec 22, 2021 Form 4/A - Amendment Insider Report for CRYO CELL INTERNATIONAL INC (CCEL)

Role
Co-CEO, Director, 10%+ Owner
Signature
/s/ Mark Portnoy
Stock symbol
CCEL
Transactions as of
Dec 22, 2021
Transactions value $
$1,497,000
Form type
4/A - Amendment
Date filed
2/8/2022, 04:00 PM
Date Of Original Report
Feb 8, 2022
Previous filing
Aug 26, 2021
Next filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CCEL Common Stock 42.3K Dec 22, 2021 By 401K
holding CCEL Common Stock 71.5K Dec 22, 2021 By Partnership F1
holding CCEL Common Stock 763K Dec 22, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCEL Stock Option Award $270K +20K $13.50 20K Dec 22, 2021 Common Stock 20K $13.50 Direct F3
transaction CCEL Stock Option Award $1.23M +100K $12.27 100K Dec 22, 2021 Common Stock 100K $12.27 Direct F4
holding CCEL Stock Option 59.5K Dec 22, 2021 Common Stock 59.5K $3.14 Direct
holding CCEL Stock Option 20K Dec 22, 2021 Common Stock 20K $7.92 Direct
holding CCEL Stock Option 22.2K Dec 22, 2021 Common Stock 22.2K $7.53 Direct
holding CCEL Stock Option 20K Dec 22, 2021 Common Stock 20K $7.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
F2 Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.
F3 The reporting person is amending his Form 4 filed on December 27, 2021 to correct an inadvertent error in reporting the exercise price of the Incentive Stock Option due to the reporting person being a 10% shareholder. Stock options vest 1/3 on the date of grant, 1/3 on December 22, 2022 and 1/3 on December 22, 2023.
F4 Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.